HNRNPK and renal cell carcinoma: Collectively, these results suggest that cP104aa interacts with HNRNPK to upregulate c‐MYC expression by inhibiting WWP2‐mediated c‐MYC ubiquitination, thereby promoting RCC proliferation and metastasis.